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Abstract
 .Previous studies have indicated that in HepG cells HDL -signalling involves glycosylphosphatidylinositol GPI2 3
anchored proteins. HDL -binding to HepG cells was found to be enhanced by cellular preincubation with PI-PLC3 2
inhibitors and sensitive to a cellular preincubation with exogenous PI-PLC, suggesting that HDL binds directly on3
GPI-anchored proteins to initiate signaling. Moreover HDL -binding was found to be partly inhibited by antibodies against3
 .the HDL-binding protein Ab .HBP
HDL , when binding to HepG cells, promoted the release in the culture medium of a 110 kDa protein that binds Ab ,3 2 HBP
 .  .while a cellular preincubation with antibodies against the inositol-phosphoglycan IPG moiety of GPI-anchor Ab , usedIPG
to block lipolytic cleavage of the GPI-anchor, inhibits HDL -induced release of the 110 kDa protein in the culture medium.3
w3 xIn H -PC prelabeled HepG cells, Ab were found to stimulate PC-hydrolysis and DAG generation within 5 min as2 HBP
did HDL stimulation. Cellular preincubation with Ab was found to inhibit only the HDL -signal and not the3 IPG 3
Ab -signal, while a prior cellular pretreatment with PI-PLC from Bacillus cereus was found to inhibit the HDL -andHBP 3
Ab -signal. Moreover cellular preincubation with Ab for 1 h at 378C was found to inhibit HDL -signalling pathways.HBP HBP 3
Our results suggest that in HepG2 cells a 110 kDa protein, which could be HBP, can be anchored to the membrane via
GPI, and can function in HDL -signalling pathways as binding sites. q 1997 Elsevier Science B.V.3
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1. Introduction
HDL -signalling properties are evidenced by the3
role of HDL in several PKC-mediated cellular func-3
tions such as cell growth, exocytosis and reverse
 w x.cholesterol transport see for review 1,2 . Numerous
w xligand-blotting studies 2,3 have revealed a variety of
 .HDL-binding proteins 58 to 140 kDa . MacKnight et
w xal. 4 reported the characterization of a HDL -bind-3
 .ing protein HBP with no hydrophobic domains, and
recently a receptor for HDL, acting in the selective
cholesterol ester uptake, has been identified by Acton
w xet al. 5 and reported to be a class B scavenger
 .receptor SR.BI . HDL -signalling most often causes3
w xbiphasic DAG generation 6–14 , but the exact iden-
tity of the HDL -binding proteins and molecular3
details of the recognition remain to be established.
There is convincing evidence indicating that bio-
logical molecules involved in cell nutriment supply
or in cell growth control, such as HDL , act via3
glycosylphosphatidylinositol-anchored proteins
 .GPI-anchored proteins which are anchored to the
outer leaflet of the plasma membrane by covalently
 . w xattached glycosylphosphatidylinositol GPI 15–18 .
Despite the lack of a cytoplasmic domain, some
GPI-anchored proteins play an important role in
transmembrane signaling processes. The hydrolysis
of the GPI-anchor has been proposed to be an early
event following the activation of a variety of growth
factor receptors such as insulin or epidermal growth
w xfactor 19,20 . Anchor hydrolysis by cellular GPI-
 .phospholipase D GPI-PLD and protease generates
 .inositol-phosphoglycan IPG that serves as the mito-
w xgenic signaling mediator 19 . GPI-anchored proteins
can also communicate with proteins associated with
w xthe intracellular face of the membrane 21–23 . In
numerous cells, cross linking of GPI-anchored anti-
gens leads to Ca2q influx, tyrosine phosphorylation
and cell proliferation, all of which are strictly depen-
dent on a membrane anchorage of these antigens by
w x GPI 23 . Caveolin a 22 kDa caveolar marker pro-
.tein is believed to transmit signals from GPI-
w xanchored proteins to Src tyrosine-kinases 21,22 .
Different experimental data suggests such a link
between HDL -signalling and GPI-anchored proteins.3
First it appears that some agents insulin and choles-
. w xterol depletion modify both HDL -binding 24,253
w xand GPI-anchored protein clustering 15,16,19 . Sec-
w xond, MacKnight et al. 4 reported the characteriza-
 .tion of a HDL -binding protein HBP which is not a3
transmembrane protein and could potentially be an-
chored by a covalently attached GPI structure. Third,
a GPI-phospholipase D and an elastase-type protease
w xare present on HDL 26 and may potentially achieve3
the lipolytic and proteolytic cleavage of the GPI-
anchor. Fielding and Fielding demonstrated that cave-
olae represent a major site of HDL -induced choles-3
w xterol efflux 27 in fibroblasts, however a retroendo-
cytic pathway is more often mentioned to function in
w xhepatocyte cholesterol transport 28 . Taken together,
these facts lead us to postulate the involvement of
GPI-anchored proteins in HDL -induced signaling3
pathways. This hypothesis has been partially corrob-
orated by several experimental results on HepG cells2
w x29,30 . Cellular preincubation with antibodies against
the inositol-phosphoglycan moiety of the GPI-anchor
 .Ab or with bacterial PI-PLC decrease theIPG
HDL -signal and suggested the involvement of spe-3
cific cleavage of GPI-anchored proteins in HDL -sig-3
w xnaling 29,30 . However additional experiments were
needed to determine whether the GPI-anchored pro-
tein is responsible for binding of HDL .3
We therefore tested the possibility of a specific
binding of HDL on GPI-anchored proteins. Accord-3
ing to our proposal, HDL -binding to the cell surface3
must be enhanced by inhibition of anchor hydrolysis
of GPI-anchored proteins. Moreover antibodies
against the protein core of GPI-anchored proteins
should result in clustering of these proteins and the
w xstimulation of related signaling pathways 23 . If
HBP represents a potential GPI-anchored protein able
to bind HDL , antibodies directed against HBP should3
be able to stimulate PC-hydrolysis.
We set out to determine whether GPI-anchored
proteins, and may be HBP, can bind HDL to initiate3
signaling pathways.
2. Materials and methods
2.1. Materials
Human hepatoma cell lines HepG were obtained2
 . w3 xfrom ATCC HB 8065 . H -PC Phosphatidyl-
w 3  .xcholine, L-a-dipalmitoyl- 2-palmitoyl-9, 10 H N
was from NEN. RHC-80267, U-73122 and U-73343
were from TEBU. Leupeptin acetyl L-leucyl-L-
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.leucyl-DL arginal , phenylmethyl-sulfonyl fluoride
 .PMSF and PI-PLC from Bacillus cereus were from
Sigma. Silica gel TLC plates were from Merck.
Peroxidase-labeled anti-rabbit immunoglobulins were
 .from Sanofi-Pasteur France . Other reagents were
from Sigma.
Rabbit antibodies against the inositol-glycan moi-
 .ety of GPI-anchored proteins Ab were kindlyIPG
provided by Dr. G. Aguie and H. Parra, and obtained
by the PI-PLC method; their specificity was checked
by preincubation with cIMP. Rabbit antibodies spe-
 .cific for HBP Ab were provided by Rhone-Pou-ˆHBP
lenc GenCell and obtained as follows. Three poly-
peptides of 14–16 aminoacids were each selected
w xusing the algorithm of Parker 31 and the hydropho-
w xbic cluster analysis method 32 in order to determine
three probably antigenic peptides. The selected se-
 .quences were 283–297 RIKKIYEEKKKKTTT ,
 .1090–1103 PDKDDGNQPQD-QIT and 1266–1279
 .PNDNDQKEQNPLQP according to the published
w xHBP sequence 33 . The peptides were synthesized
on an Applied Biosystems 431A apparatus Applied
.Biosystems, Roissy, France and coupled to rabbit
serum albumin or keyhole limpets hemocyanin using
w xa procedure described in 34 . A mixture of the three
 .antibodies 1r1r1, wrwrw were either used for
immunoblotting or for cell stimulation. For all anti-
 .bodies Ab or Ab , a partial purification wasIPG HBP
 .obtained by 18% wrv sodium sulfate precipitation
and extensive dialysis against Phosphate Buffer Saline
 .PBS .
2.2. HepG cell culture2
Cells of the human hepatoma line HepG were2
grown routinely in 75 cm2 flasks in 15 ml of DMEM
 .Dubelcco’s Modified Eagles Medium, Gibco con-
 .  .taining 10% vrv fetal calf serum, 3% wrv glu-
 .tamine, 0.2% wrv NaHC0 , 1000 Urml penicillin3
and 1000 mgrml streptomycin at 378C in equilibra-
tion with 95% airr5% CO . The medium was re-2
placed twice a week. For experiments, HepG cells2
were cultured in 6-well tissue culture plates until
around 80% confluence was achieved. 24 h before
the assays, the culture medium was replaced by
DMEM containing the above additions, except for the
fetal calf serum which was replaced by 10% LPDS
 .DMEM-LPDS medium .
2.3. Lipoprotein isolation
HDL was isolated from human serum by standard3
w x differential ultracentrifugal flotation 35 HDL ds3
.1.125 to 1.210 grml . Its protein content was mea-
w xsured by the procedure of Petersen 36 . Apolipopro-
tein E constituted less than 0.2% of the total HDL 3
protein. Sodium dodecyl sulfate-polyacrylamide gel
 .electrophoresis SDS-PAGE performed on a 7% gel
indicated that HDL was pure from any plasmatic3
protein contaminants. For routine use, HDL was3
stored at 48C less than 8 days. HDL was radiola-3
belled by 125I-Iodine according to the procedure of
w xBilheimer et al. 37 . HDL -proteasic activities were3
inhibited by pre-incubating HDL in the presence of3
1 mM leupeptinrPMSF for 5 min at 378C; the excess
o f in h ib ito rs w as n o t d isca rd ed an d
leupeptinrPMSF-pretreated HDL preparations were3
also containing free inhibitors.
[ 3 ]2.4. H -Phosphatidylcholine prelabeled HepG2
cells
After removal of conditioning DMEM-LPDS
w3 xmedium, HepG cells were prelabeled with H -2
phosphatidylcholine 0.75 mCirml DMEM contain-
 .ing 1% wrv BSA for 2 h at 378C. Incorporation of
w3 xH -PC into cells was found to give around 350 000
cpmrwell. Nearly all the radioactivity was associated
w xwith the phosphatidylcholine fraction 6–9 .
2.5. 1,2-diacylglycerol assay
An excess of labeling medium was removed, and
cells were rinsed first with PBS-BSA solution 140
mM NaCl, 2.7 mM KCl, 8 mM Na HPO , 1.5 mM2 4
.KH PO , 1% BSA wrv, pH 7.4 , then washed twice2 4
in PBS solution, and exposed to 1 ml DMEM con-
taining 50 mgrml HDL or to l00 mgrml antibodies3
 .against HBP Ab or 100 mgrml immuno-HBP
 .globulins from non immunized rabbits control-Ab ,
for the indicated time at 378C. To terminate the
incubation, the medium was removed, and dishes
chilled on ice. Cells were first rinsed with PBS-BSA
solution, then twice with PBS, and scraped from the
dishes with a rubber policeman. The lipids were
w xextracted as described by Folch et al. 38 , spotted on
silica gel 60 thin-layer chromatography plates and
developed with petroleum etherrethyl etherracetic
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 .acid 90r10r5 vrvrv to separate DAG. The ra-
dioactive spots corresponding to DAG and PC were
cut out and processed for radioactivity counting. A
good correlation for DAG release was found between
w3 x w xthe H -PC method and the DAG kinase assay 6 .
HDL -induced DAG generation was shown to be3
biphasic with an early phase peaking at 4 min, and a
w xlate phase at 10 min 29,30 , however only the early
phase of signaling was investigated here and time
course studies were observed within 4 min.
w3 xFor specific procedures, H -PC prelabelled
HepG cells were preincubated at 378C for 1 h in the2
presence of 200 mgrml of Ab or of 100 mgrmlIPG
Ab or of 100 mgrml control Ab. The mediumHBP
was then discarded and cells assayed as usual for
HDL -induced or Ab -induced DAG release. To3 HBP
w3 xremove GPI-anchored proteins, H -PC prelabelled
HepG cells were preincubated for 2 h at 378C with2
0.5 Urml PI-PLC. The medium was discarded and
cells processed for assay of HDL - or Ab -induced3 HBP
DAG release.
Results are expressed in cpm of DAG obtained for
w3 xa standard incorporation of 350 000 cpm of H -PC
and per mg of cellular proteins, after base-line DAG
is subtracted. Base-line DAG represented 852"12
w3 xcpmr350 000 cpm H -PCrmg of proteins, and was
not significantly affected by any treatment U-test:
.NS . Control-Ab were found to generate 8–10 cpm of
w3 xDAGr350 000 cpm H -PCrmg of proteins when
base-line DAG is subtracted.
2.6. Binding assays
Binding of labeled lipoproteins to HepG cells was2
w xperformed for 2 h at 48C as previously described 39 .
Briefly, after 1 h incubation in DMEM at 378C, cell
monolayers were incubated in PBS with labeled and
with or without unlabeled ligands and then washed
twice with ice-cold PBS maximum washing time: 15
.s . To determine the cell-associated radioactivity, 500
ml of 0.1 N NaOH was added to the washed mono-
layer. The NaOH digest was used for protein determi-
nation and radioactivity measurement. Non-specific
binding was determined in the presence of a 20-fold
excess of the corresponding unlabeled HDL . The3
ratio of bound to free 125I-apolipoprotein versus bound
125I-apolipoprotein was plotted according to
Scatchard.
For specific procedures, HDL -binding was mea-3
sured after cellular preincubation in the presence of
200 mgrml Ab or of control immunoglobulinsHBP
from non-immunized rabbits for 1 h at 378C, or of
phospholipase inhibitors i.e. 10 mM RHC-80267 in-
. hibitor of cellular PC-PLC , 10 mM U-73122 specific
. inhibitor of cellular PI-PLC , 10 mM U-73343 a
.close structural inactive analog of U-73122 for 10
min at 378C, or of 1 Urml exogenous PI-PLC for 1 h
at 378C. Then HDL -binding was determined in the3
presence of the same concentrations of Ab 200HBP
.  .  .mgrml , RHC-80267 10 mM , U-73122 10 mM or
 .U-73343 10 mM .
Control immunoglobulins from non-immunized
rabbits were not able to counteract HDL -binding3
2.7. Release of HBP into the culture medium
 2 .HepG cells in 75 cm dishes were preincubated2
for 30 min at 378C in the presence of 50 mgrml
colchicine. After 2 washing steps with PBS, cells
were stimulated for 4 min with 50 mgrml HDL or3
with 50 mgrml leupeptinrPMSF-pretreated HDL .3
The medium from two dishes was collected, dialyzed,
lyophilized and solubilized in sample buffer. Elec-
w xtrophoresis was performed according to Laemmli 40
 .in polyacrylamide gel 4–15% gradient . Separated
proteins were transferred onto nitrocellulose at 2
2 w xmArcm for 2 h, as described by Towbin 41 , then
nitrocellulose strips were incubated for 1 h with
blocking buffer PBS pH 7.4 containing 10% non fat
.milk . For immunoblotting, nitrocellulose strips were
incubated overnight at q48C with antibodies against
 .HBP 30 mgrml , washed and then incubated with
the peroxidase-labeled anti-rabbit immunoglobulins,
 .diluted in blocking buffer 1r2000 . For specific
procedures, cells were preincubated with 50 mgrml
colchicine for 30 min at 378C, then washed, and
preincubated with 200 mgrml Ab for 1 h at 378C,IPG
and processed as previously for HDL -induced HBP3
release.
2.8. Data presentation
Values represent the mean"standard deviation for
triplicate determinations. Results are representative of
at least 3 or 4 separate experiments.
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3. Results
3.1. Inhibition of phospholipases modifies HDL -bi-3
nding
Several hypotheses can account for the mechanism
 .used by HDL to cleave the GPI-anchor: a HDL3 3
binds to a transmembrane protein thus initiating a
cascade of activation events leading to the release of
GPI-anchored proteins from the membrane as insulin
w x  .does 15 , or b HDL binds directly on a GPI-3
anchored protein and stimulates the cleavage of its
docking agent. In the latter case HDL -binding to3
HepG cells should be modulated by inhibitors of2
phospholipases or of proteases.
We further investigated the binding capacities of
HDL on HepG cells. HDL , radiolabelled by3 2 3
w125 xI -iodine, was incubated with HepG cells for 2 h2
at 48C. The incubation mixture was then processed
for determination of total and specific binding, and
 .Scatchard transformation of total binding Fig. 1 .
Specific binding of HDL was shown to be saturable.3
Scatchard analysis of the data revealed two classes of
binding sites: one with a high affinity K values ofd
.0.8 mgrml and a second with a moderate affinity
 .K value of 7.7 mgrml .d
We then investigated the binding capacities of
HDL in the presence of several phospholipase in-3 125  .hibitors. I-HDL 7.5 mgrml was incubated with3
cells for 2 h at 48C in the presence or not of 10 mM
 .RHC-80267 an inhibitor of PC-specific PLC or 10
 .mM U-73122 an inhibitor of PI-specific PLC or 10
mM U-73343 an inactive structural analog of U-
w125 xFig. 1. Scatchard representation and binding curves of I -
w125 xlabeled HDL to HepG cells. Specific binding of I -labeled3 2
HDL was measured after 2 h of incubation at 48C. Non specific3
binding was assessed as described under experimental proce-
dures. The solid line represents the best fit composed of high and
 .moderate affinity binding sites dashed lines . The mean values"
SD from duplicate wells are reported and are representative of 3
independent experiments. Inset: corresponding binding curves of
w125 x w125 xI -labeled HDL to HepG cells. Total binding of I -3 2
 .  .labeled HDL v ; specific binding ‘ ; non-specific binding3
 .D .
.73122 . Cells were then processed for the determina-
 .tion of total and specific HDL -binding Table 1 .3
A problem with this approach is that binding
experiments are usually performed at 48C to mini-
mize enzyme activities. Surprisingly, even at 48C,
HDL -binding was modified by the presence of U-3
73122, a PI-PLC inhibitor. A 1.52-fold increase in
the binding of HDL was registered in the presence3
Table 1
Role of phospholipase inhibitors on HDL -binding to HepG cells3 2
Specific binding ng of bound % of specific
HDL rmg of cell proteins binding3
w xC qHDL 2.05"0.12 1003
w xCqRHC-80267 qHDL 2.13"0.33 1033
w xCqU-73122 qHDL 3.08"0.45 1503
w xCqU-73343 qHDL 2.04"0.17 993
w xCqPI-PLC qHDL 1.84"0.13 903
w xCqAb qHDL 1.53"0.28 75HBP 3
w125 x w xBinding of 7.5 mgrml I -labeled HDL was measured after 2 h of incubation at 48C in the absence C , or in the presence of active3
w x w x w xinhibitors of PC-PLC CqRHC-80267 or of PI-PLC CqU-73122 , in the presence of inactive inhibitors of PI-PLC CqU-73343 or
w x w xafter pretreatment with exogenous PI-PLC CqPI-PLC or with Ab CqAb . Radioactivity was measured as described in theHBP HBP
method section. Control immunoglobulins from non-immunized rabbits were not able to counteract HDL -binding. Preincubation steps3
are shown in brackets.
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of U-73122, while the inactive U-73343 or RHC-
80267 which rather inhibited PC-PLC was not able to
modify HDL -binding. To validate the involvement3
of GPI-anchored proteins in lipoprotein-binding,
HDL -binding was measured after cellular preincuba-3
tion in the presence of 1 Urml exogenous PI-PLC
for 1 h at 378C. Results are reported in Table 1.
Cellular pretreatment with exogenous PI-PLC only
 .slightly 10% inhibited HDL -binding. The partial3
binding inhibition registered after cellular pretreat-
ment with bacterial PI-PLC suggested the existence
of HDL -binding proteins which can be anchored via3
a GPI core. As, there is a variety of HDL -binding3
w xproteins revealed by ligand-blotting studies 2,3 ,
GPI-anchored proteins might represent only one class.
Taken together these results suggested that HDL 3
partly binds to a GPI-anchored protein and initiate its
signaling pathways by the cleavage of the GPI-anchor.
3.2. HDL stimulates the release of HBP into the3
culture medium
The above experiment indicated that HDL binds,3
at least in part, to GPI-anchored proteins and acts by
releasing its docking molecule in the extracellular
medium. If HBP is anchored to the membrane via a
GPI-anchor and serves as HDL -binding sites, it3
must be released into the medium upon cellular stim-
ulation by HDL . A complete cleavage of GPI-anchor3
would involve specific phospholipases and proteases
w x w xwhich can be cellular 19 or associated to HDL 26 .
We used antibodies against the inositol phosphogly-
 .can moiety Ab which bind specifically to theIPG
GPI-anchor, to inhibit GPI-specific phospholipases,
or leupeptin inhibitor of calcium dependent neutral
. proteases and PMSF known to inhibit for instance
w x.elastase 42 to inhibit the proteolytic step and to
release incompletely cleaved GPI-anchored proteins
 .still bearing a residual IPG moiety into the culture
w xmedium. As an elastase is associated to HDL 26 ,3
protease inhibitors were first added to HDL , and3
then in excess during cellular stimulation.
To assess the role of HBP in HDL -binding,3
lipoprotein-binding was measured after cellular prein-
cubation in the presence of antibodies against HBP
 .Ab . Results reported in Table 1 indicated thatHBP
Ab produced a 25% inhibition in HDL -binding.HBP 3
The incomplete inhibition registered in the presence
Fig. 2. HDL promotes the release of proteins that bind Ab .3 HBP
HepG cells were preincubated for 30 min at 378C with 502
mgrml colchicine and then for 1 h at 378C with 200 mgrml
 .  .Ab lane D or not lanes A, B, C . The medium wasIPG
discarded and cells were stimulated with 50 mgrml HDL for 43
 .min at 378C lanes B, D or with 50 mgrml HDL pretreated for3
 .5 min at 378C with 1 mM leupeptinrPMSF lane C or with PBS
 .as control lane A . The culture medium was collected, and the
released proteins were analyzed by SDS-PAGE and immuno-
blotting with Ab .HBP
of Ab validate the fact that among all the listedHBP
HDL -binding proteins, HBP might represent only3
one of them.
To evidence an eventual release of HBP, HepG2
cells were preincubated with 50 mgrml colchicine to
inhibit the secretion route, and then incubated in the
presence or not of 200 mgrml Ab before beingIPG
stimulated with 50 mgrml HDL or with 50 mgrml3
leupeptinrPMSF-pretreated HDL . The culture3
medium was collected and subjected to SDS-PAGE
analysis. Immunoblotting was realized with antibod-
 .ies against HBP Ab to detect the presence ofHBP
HBP in the medium. Results are reported in Fig. 2.
 .HDL Fig. 2 lane B was found to promote the3
release into the culture medium of a 110 kDa protein
which was able to bind Ab . Cellular preincuba-HBP
 .tion with Ab Fig. 2 lane D , used to inhibitIPG
GPI-anchor lipolysis, prevented HDL from releasing3
the 110 kDa protein into the culture medium. On the
other hand HDL -preincubation with leupep-3
 .tinrPMSF Fig. 2 lane C , used to impair only the
proteolytic cleavage of GPI-anchored proteins, was
unable to prevent HDL from liberating the 110 kDa3
protein into the medium. Exocytosis cannot account
for the HDL -induced release of the 110 kDa protein,3
as it was blocked by colchicine.
These results strongly support the hypothesis that
HBP can be a GPI-anchored protein which is sepa-
rated from its GPI-anchor and released into the extra-
cellular medium upon HDL -binding.3
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3.3. Antibodies specific for HBP stimulate PC-hy-
drolysis
To investigate the role of HBP in the HDL -signal,3
we set out to examine the ability of antibodies against
HBP to stimulate specific signaling pathways. If HBP
is anchored to the membrane via GPI to serve as
HDL -binding sites, it could induce signal activation3
w xupon interaction with specific antibodies 43 . In
order to evidence the signaling capacities of antibod-
 .ies against HBP Ab , HepG cells were prela-HBP 2
w3 x w3 x .belled with H -phosphatidylcholine H -PC , and
then challenged with freshly prepared HDL 503
.  .mgrml , or with Ab 100 mgrml or with im-HBP
munoglobulins from non immunized rabbits as con-
 .trol 100 mgrml . Results are reported Fig. 3.
w3 xIn H -PC prelabelled HepG cells, HDL rapidly2 3
stimulated PC hydrolysis giving rise to an early peak
in DAG production which was maximum at 4 min.
Ab were also found to promote PC-hydrolysis,HBP
and to generate DAG within 5 min, with a maximum
efficiency at 3 min, while control immunoglobulins
from non immunized rabbits were not able to pro-
mote PC-hydrolysis into DAG.
Thus both HDL and Ab are able to produce3 HBP
second messengers, however signaling pathways
linked to HDL or to Ab might be different. The3 HBP
former has been found to involve anchor hydrolysis
w xof GPI-anchored proteins 29,30 , the latter if involv-
ing cross-linking of GPI-anchored proteins should not
cleave the GPI-anchor. To further investigate the
involvement of anchor cleavage in HDL - or in3
Ab -induced signaling pathways, antibodies againstHBP
 .the IPG moiety Ab were used to bind specifi-IPG
Fig. 3. Antibodies against HBP stimulated PC hydrolysis. HepG2
w3 xcells were prelabelled with 0.75 mCirml H -PC. After washing
steps cells were incubated for 2 h at 378C with 0.5 Urml PI-PLC
w xfrom Bacillus cereus CqPI-PLC or for 1 h at 378C with 200
w x w xmgrml Ab CqAb or not C . The medium was dis-IPG IPG
carded, and HepG cells were stimulated for the indicated time at2
378C with 50 mgrml HDL or with 100 mgrml Ab . DAG3 HBP
radioactivity was measured as described in method section. Con-
trol-Ab were found to generate 8–10 cpm of DAGr350000 cpm
w3 xH -PCrmg of proteins when base-line DAG is subtracted.
cally to the GPI-anchor and to inhibit its hydrolysis.
w3 xH -PC prelabelled HepG cells were preincubated2
for 60 min with 200 mgrml Ab and processed forIPG
standard HDL - or Ab -induced DAG assay Fig.3 HBP
.3 . The binding of specific Ab prevented HDLIPG 3
from triggering PC-hydrolysis, but was less efficient
in inhibiting Ab -induced DAG generation, hintingHBP
that signaling pathways related to Ab did notHBP
imply the hydrolysis of the GPI-anchor. Moreover
cellular pretreatment with exogenous PI-PLC, which
resulted in the release of GPI-anchored proteins into
the culture medium decreased both HDL - and3
 .Ab -signaling capacities Fig. 3 .HBP
Table 2
Long-term effect of cellular preincubation with Ab on HDL -signalHBP 3
 .Early phase of DAG generation 4 min % of maximal
in cpmrmg of cell proteinsr350 000 cpm DAG generation
3w xof incorporated H PC
w xC qHDL 3000"100 100"3.33
w xC qAb 2459" 70 81.96"2HBP
w xCqAb qHDL 2104" 50 71.4"1.6HBP 3
w xCqAb qAb qHDL 1003" 51 33"1.6IPG HBP 3
w xCqAb qHDL 3120" 60 104"2control 3
w3 xHepG cells were prelabelled with 0.75 mCirml H -PC. After washing steps, cells were preincubated for 1 h at 378C with 100 mgrml2
w x w x wAb in the presence CqAb qAb or the absence CqAb of 200 mgrml Ab , or with 100 mgrml control Ab CqAbHBP IPG HBP HBP IPG
xcontrol . The medium was discarded, and HepG cells were stimulated for 4 min at 378C with 50 mgrml HDL . DAG radioactivity was2 3
measured as described in Section 2. Preincubation steps are shown in brackets.
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These results suggest that GPI-anchored proteins
are involved in the signaling cascades of both HDL3
and Ab , and that HBP could potentially be aHBP
GPI-anchored protein.
3.4. Cellular preincubation with Ab inhibitsHBP
HDL -signaling3
The above experiments indicated that Ab canHBP
stimulate signaling pathways, without cleaving GPI-
anchors. We therefore examined the effect of a long-
term cellular stimulation by Ab on the HDL -in-HBP 3
w3 xduced signaling pathway. H -PC prelabelled HepG2
cells were preincubated or not in the presence of 100
mgrml Ab andror 200 mgrml Ab for 60 minHBP IPG
before being stimulated with 50 mgrml HDL . Re-3
sults are shown Table 2.
The in vitro DAG assay indicated that long-term
cellular preincubation with Ab modified HDL -HBP 3
signalling capacities, the residual HDL -induced sig-3
nal is sensitive to the presence of Ab . Preincuba-IPG
tion with both Ab and Ab fully blocked theHBP IPG
HDL -signal. The decreased HDL -ability to gener-3 3
ate DAG after cellular treatment with Ab could beHBP
caused either by inhibition of HDL -binding or by3
the clustering of GPI-anchored proteins resulting in a
kind of desensitization pathway.
4. Discussion
Our proposal for a HDL -signalling pathway is3
that native lipoproteins stimulate the lipolytic and
proteolytic cleavage of GPI-anchored proteins, thus
generating an array of potential signaling mediators
that activate in their turn a PC-PLC involved in the
w xearly phase of DAG production 29,30 . We set out to
determine whether these GPI-anchored proteins can
bind HDL to initiate signaling pathways. The pro-3
posal of an HBP anchored to the membrane via GPI,
that serves as binding site and functions in HDL -sig-3
naling was investigated.
The possibility that HDL binds to GPI-anchored3
proteins and promotes the release of its docking
protein into the medium was an intriguing question.
There is some evidence that agents which impair the
expression of GPI-anchored proteins on plasma mem-
w xbrane 15,16,19 are found to decrease HDL -binding3
w xto the cell surface 24,25 and related signaling path-
w xways 29,30 . Cellular pretreatment with PI-PLC or
with insulin was found to release several proteins that
w xbind HDL or Ab , in the culture medium 29,30 .3 IPG
In this context HDL -binding, if involving GPI-3
anchored proteins, must be enhanced by any agent
that renders GPI-hydrolysis impossible. As predicted
cellular preincubation with active inhibitors of PI-PLC
 .U-73122 increased HDL -binding, while inhibitors3
of PC-specific phospholipases C were not able to
significantly modify the lipoprotein-binding. More-
over a prior cellular incubation with bacterial PI-PLC,
used to release GPI-anchored proteins in the culture
medium, was found to decrease HDL -binding. The3
incomplete inhibition registered after PI-PLC treat-
ment indicated that among all the listed HDL -bind-3
ing proteins, GPI-anchored proteins might represent
only one of them.
w xAs MacKnight et al. 4 reported the characteriza-
 .tion of a HDL -binding protein HBP which is not a3
transmembrane protein, we set out to indirectly
demonstrate that HBP could be anchored by a cova-
lently attached GPI structure. According to this hy-
pothesis, HBP could be able to signal upon cross-lin-
king with specific antibodies. It has been shown on
several cell types that perturbation of GPI-anchored
proteins by cross-linking rapidly induces cell activa-
tion as assessed by Ca2q influx, generation of reac-
tive oxygen metabolites, inositol phosphate turnover,
w xcytokine release or mitosis 42–44 . Cell activation
after cross-linking of GPI-anchored proteins is proba-
bly facilitated through interactions with tyrosine-
w xkinase attached to the membrane by acyl chains 45 .
The GPI core is an essential prerequisite for signaling
w x46–48 . It appears that HBP signals upon interaction
with its antibodies, hinting that it could be anchored
via a GPI moiety. DAG is generated by PC hydroly-
sis within 4 min after addition of Ab . The signal-HBP
ing capacity of HBP-Ab complexes does not relyHBP
on the hydrolysis of the GPI-anchor by concerted
action of lipases and proteases, as DAG production is
still recorded in cells preincubated with Ab beforeIPG
Ab addition. In contrast the presence of AbHBP IPG
fully blocks HDL -signalling. The small decrease in3
the signaling capacity of HBP-Ab , observed inHBP
the presence of Ab , can be due to the presence ofIPG
Ab on the possible GPI-anchor of HBP. Proof thatIPG
HBP signaling after Ab -interaction was not anHBP
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artifact was provided by our demonstration that long
term preincubation of HepG with Ab counteracts2 HBP
HDL -induced signaling pathways; HDL -induced3 3
DAG generation represents only 71% of DAG values
in control experiments. It appears that Ab whenHBP
associated with HBP prevents HDL from signaling.3
 .Two hypothesis can account for these results; a
HDL binds to HBP and Ab inhibits HDL -bind-3 HBP 3
 .ing and the related signaling pathways, b AbHBP
mobilizes GPI-anchored proteins and impairs HDL -3
related signaling pathways by a kind of heterologous
desensitization phenomenon. To ascertain this ques-
tion we investigated the role of a cellular preincuba-
tion in the presence of Ab on HDL -binding. AsHBP 3
expected, HBP was found to inhibit HDL -binding to3
HepG2 cells, suggesting that it acts as binding sites.
The final aim of this study was to demonstrate that
HBP is released into the medium after hydrolysis of
its possible GPI-anchor upon HDL -binding. When3
HDL stimulates HepG cells, a 110 kDa protein3 2
which reacts with Ab , is released into the cultureHBP
medium in conditions which inhibit any secretion. In
contrast, the presence of Ab , which were used toIPG
block phospholipasic attack of the GPI-anchor, fully
inhibits the HDL -induced release of this 110 kDa3
protein. These results clearly demonstrate that HBP is
released into the culture medium upon HepG stimu-2
lation by HDL , and suggest that HBP may belong to3
the family of GPI-anchored proteins. The unusual
w xabsence of hydrophobic domains in HBP 4,32 is
consistent with this concept. The present findings
appear to be the first directly implicating HBP in
HDL -induced signaling pathways.3
It is interesting that both the binding and the
functions of HDL are dependent on GPI-anchored3
proteins and caveolae. Caveolae are clathrin-free in-
w xvaginations of many cell surfaces 49 , their mem-
branes are enriched in GPI-anchored proteins, Src-
w xfamily tyrosine-kinases and G-proteins 21–23 . If
cells are treated with sterol binding drugs such as
filipin, digitonin or with cholesterol oxidase, the
caveolar coat disassembles, the caveolar domains be-
w x w xcome flattened 49 , while HDL -binding 24 and3
w xHDL -signalling 29,30 are impaired. The dramatic3
effect of cellular pretreatment with insulin on HDL -3
w x w xbinding 25 and signaling 29,30 can be mediated by
the cleavage of the GPI-anchor, as HDL binds first3
to a GPI-anchored protein and then signals. Moreover
Fielding and Fielding have recently proposed that
caveolae represent a major site of HDL -induced3
w xcholesterol efflux 27 , as the caveolar membrane
contains much of the free cholesterol in the outer
w xleaflet of the membrane bilayer 50 . In addition
caveolin, through its cholesterol binding property,
serves a specific function in membrane microdomain
w xformation 51 . Our findings suggest a direct link
between the caveolar proteins GPI-anchored pro-
.teins and HDL functions. A retroendocytic pathway3
w xis often mentioned to function in hepatocytes 28 .
However it is difficult to delineate the precise contri-
bution of all the vesicles caveolae or endocytic
.vesicles that can carry and recycle HDL . Thus the3
link between HDL and caveolar proteins GPI-3
.anchored proteins and the existence of a retroendo-
cytic pathway do not contradict each other.
Thus we might envisage that HBP is a GPI-
anchored protein that serves in HDL -binding and3
signaling. Further research will be required to estab-
lish definitively the anchoring mechanism of HBP,
but the presence of GPI-anchored proteins and HBP
may be important factor in determining HDL -signal.3
Acknowledgements
This work was supported by grants from INSERM
and Institut Pasteur. The authors are very grateful to
G. Aguie and H. Parra for kindly providing antibod-
ies against the GPI-anchor, to C. Copin for her
technical assistance, and to A. Walters for his edito-
rial corrections.
References
w x  .1 G. Ailhaud, Curr. Opin. Lipidol. 3 1992 222–226.
w x  .2 C.J. Fielding, P.E. Fielding, J. Lipid Res. 36 1995 211–
228.
w x3 M.N. Pieters, D. Schouten, F.J.C. Van Berkel, Biochim.
 .Biophys. Acta 1225 1994 125–134.
w x4 G.L. MacKnight, J. Reasoner, T. Gilbert, K.O. Sundquist,
B. Hokland, P.A. McKernan, J. Champagne, C.J. Johnson,
M.C. Bailey, R. Holly, P.J. O’Hara, J.F. Oram, J. Biol.
 .Chem. 267 1992 12131–12141.
w x5 S. Acton, A. Rigotti, K.T. Landschulz, S. Xu, H.H. Hobbs,
 .M. Krieger, Science 271 1996 518–520.
w x6 N. Theret, C. Delbart, G. Aguie, J.C. Fruchart, G. Vassaux,
 .G. Ailhaud, Biochem. Biophys. Res. Comm. 173 1990
1361–1368.
( )F. Nazih-Sanderson et al.rBiochimica et Biophysica Acta 1358 1997 103–112112
w x7 H. Nazih, D. Devred, F. Martin-Nizard, J.C. Fruchart, C.
 .Delbart, Thrombosis Res. 59 1990 913–920.
w x8 H. Nazih, D. Devred, F. Martin-Nizard, V. Clavey, J.C.
 .Fruchart, C. Delbart, Thrombosis Res. 67 1992 559–567.
w x9 H. Nazih, F. Nazih-Sanderson, V. Magret, B. Caron, J.
Goudemand, J.C. Fruchart, C. Delbart, Arterioscler. Thromb.
 .14 1994 1321–1326.
w x10 D.E. Myers, N.H. Fidge, H. Stanton, R.G. Larkins,
 .Atherosclerosis 92 1992 9–16.
w x11 V.N. Bochkov, V.A. Tkachuk, A.W.A. Hahn, J. Bernhardt,
 .F.R. Buhler, T.J. Resink, Arterioscler. Thromb. 13 1993
1261–1269.
w x12 J.R. Nofer, M. Walter, B. Kehrel, U. Seedorf, G. Assmann,
 .Biochem. Biophys. Res. Comm. 207 1995 148–154.
w x13 W. Drobnik, C. Mollers, T. Resink, G. Schmitz, Arte-¨
 .rioscler. Thromb. Vasc. Biol. 15 1995 1369–1377.
w x14 C. Mollers, W. Drobnik, T. Resink, G. Schmitz, Cellular¨
 .signalling 7 1995 695–707.
w x  .15 M.G. Low, Biochem. Biophys. Acta 988 1989 427–454.
w x  .16 M.A.J. Ferguson, Curr. Opin. Struct. Biol. 1 1991 522–
529.
w x17 K. Hanada, M. Nishijima, Y. Akamatsu, R.E. Pagano, J.
 .Biol. Chem. 270 1995 6254–6260.
w x  .18 R.G. Parton, K. Simons, Science 269 1995 1398–1399.
w x  .19 G. Romero, J. Larner, Advances Pharmacol. 24 1993
21–50.
w x20 R. Clemente, D.R. Jones, P. Ochoa, G. Romero, J.M. Mato,
 .I. Varela-Nieto, Cellular signalling 7 1995 411–421.
w x  .21 R.G.W. Anderson, Proc. Natl. Acad. Sci. USA 90 1993
10909–10913.
w x22 M.P. Lisanti, Z. Tang, P.E. Scherer, E. Kubler, A.J. Koleske,¨
 .M. Sargiacomo, Mol. Memb. Biol. 12 1995 121–124.
w x  .23 P.J. Casey, Science 268 1995 221–225.
w x24 F. Bernini, S. Bellosta, A. Corsini, F.M. Maggi, R. Fuma-
galli, A.L. Catapano, in: High Density Lipoproteins Phys-
iopathology and Clinical Relevance Raven Press, Ltd. New
York, 1993, pp. 99–109.
w x25 A. Corsini, R. Fumagalli, A.L. Catapano, in: A.L. Catapano,
 .F. Bernini, A. Corsini Eds. , High Density Lipoproteins
Physiopathology and Clinical Relevance Raven Press, Ltd.
New York, 1993, pp. 111–118.
w x  .26 M.I. Mackness, P.N. Durrington, Atherosclerosis 115 1995
243–253.
w x  .27 P.E. Fielding, C.J. Fielding, Biochemistry 34 1995 14288–
14292.
w x28 J.G. DeLamatre, T.G. Sarphie, R.C. Archibold, C.A. Hor-
 .nick, J. Lipid Res. 31 1990 191–202.
w x29 F. Nazih, S. Nion, G. Pinchon, S. Lestavel, J.C. Fruchart, V.
 .  .Clavey, C. Delbart, Circulation Suppl. 92 1995 3314–
3314.
w x30 F. Nazih, G. Pinchon, S. Nion, J.C. Fruchart, C. Delbart,
 .Biochim. Biophys. Acta 1346 1997 45–60.
w x  .31 J.M. Parker, D. Guo, R. Hodges, Biochemistry 25 1986
5425–5432.
w x32 C. Gaboriaud, V. Bissery, T. Benchetrit, J.P. Mornon, FEBS
 .Lett. 224 1987 149–155.
w x33 J.F. Oram, G.L. McKnight, C.E. Hart, D.A. Curtiss, Acces-
sion number R05531, patent number WO 9005744-A Lo, in
Geneseq data bank.
w x  .34 A.G. Gitman, I. Kahane, A. Loyter, Biochemistry 24 1985
2762–2768.
w x  .35 R.J. Havel, H. Heder, J.H. Bradgon, Clin. Invest. 3 1955
1345–1353.
w x  .36 G.L. Petersen, Ann. Biochem. 83 1977 346–356.
w x37 D.W. Bilheimer, S. Eisenberg, R.I. Levy, Biochim. Biophys.
 .Acta 260 1972 212–221.
w x38 J. Folch, M. Less, G.H. Sloane-Stanley, J. Biol. Chem. 228
 .1957 497–509.
w x39 J. Luchoomun, N. Theret, V. Clavey, P. Duchateau, M.´
Rosseneu, R. Brasseur, P. Denefle, J.C. Fruchart, G.R.
 .Castro, Biochim. Biophys. Acta 1212 1994 319–326.
w x  .40 U.K. Laemmli, Nature 277 1970 680–685.
w x41 H. Towbin, T. Stachlin, J. Gorden, Proc. Natl. Acad. Sci.
 .USA 76 1979 4350–4354.
w x42 B.P. Morgan, C.W. Van den Berg, E.V. Davies, M.B.
 .Hallett, V. Horejsi, Eur. J. Immunol. 23 1993 2841–2850.
w x  .43 P.J. Robinson, Immunol. Today 12 1991 35–41.
w x  .44 D.A. Brown, Curr. Opin. Immunol. 5 1993 349–354.
w x45 I. Stefanova, V. Horejsi, I.J. Ansotegui, W. Knapp, H.
 .Stockinger, Science 254 1991 1016–1019.
w x46 A.M. Shenoy-Scana, J. Kwong, T. Fujita, M.W. Olszowy,
 .A.S. Shaw, D.M. Luplin, J. Immunol. 149 1992 3535–
3541.
w x47 M.C. Tiveron, M. Nosten-Bertrand, H. Jani, D. Garnett,
E.M.A. Hirst, F. Grosveld, R.J. Morris, J. Cell Sci. 107
 .1994 1783–1796.
w x48 C.W. Van den Berg, T. Cinek, M.B. Hallett, V. Horejsi,
 .B.P. Morgan, J. Cell. Biol. 131 1995 669–677.
w x49 K.G. Rothberg, Y.S. Ying, B.A. Kamen, R.G.W. Anderson,
 .J. Cell Biol. 111 1990 2931–2938.
w x50 E.J. Smart, Y.S. Ying, P.A. Conrad, R.G.W. Anderson, J.
 .Cell Biol. 127 1994 1185–1197.
w x51 M. Murata, J. Peranen, R. Schreiner, F. Wieland, T.V.¨
Kurzchalia, K. Simons, Proc. Natl. Acad. Sci. USA 92
 .1995 10339–10343.
